THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER-SUMOYLATION IN CHOLANGIOCARCINOMA
Paula Olaizola 1, 2
Irene Olaizola 2
Marta Fernandez de Ara 2
Maite G. Fernandez-Barrena 2, 3, 4
Laura Alvarez 4
Mikel Azkargorta 2, 5
Colm J. O'Rourke 6
Pui-Yuen Lee-Law 1, 7
Luiz M. Nova-Camacho 8
Jose JG Marin 2, 9
Maria L. Martinez-Chantar 2, 10
Matias A. Avila 2, 3, 4
Patricia Aspichueta 2, 11, 12
Felix Elortza 2, 5
Jesper B. Andersen 5
Luis Bujanda Fernández de Piérola 1, 2
Pedro M. Rodrigues 1, 2, 13
María Jesús Perugorria 1, 2, 14
Jesús M. Bañales 1, 2, 13
1 Biodonostia Health Research Institute - Donostia University Hospital, San Sebastian, Spain
2 National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, “Instituto de Salud Carlos III”), Madrid, Spain
3 Hepatology Program, CIMA, University of Navarra, Pamplona, Spain
4 Instituto de Investigaciones Sanitarias de Navarra
5 Proteomics Platform, CIC bioGUNE, CIBERehd, ProteoRed-ISCIII, Bizkaia Science and Technology Park, Derio, Spain
6 Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
7 Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
8 Osakidetza Basque Health Service, Donostialdea IHO, Donostia University Hospital, Department of Pathology, San Sebastian, Spain
9 Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, Institute of Biomedical Research of Salamanca (IBSAL),
10 Liver Disease Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Spain
11 Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain
12 Biocruces Bizkaia Health
13 IKERBASQUE, Basque Found
14 Faculty of Medicine and
Topic
Hepatobiliary
Session
PP 07 Liver & biliary (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]